Clinical Data of 31 Patients With Primary Large B-Cell Lymphomas of the GI Tract
Case . | Sex/Age . | Organ . | Initial Stage-150 . | Current Status . | Survival in mo . |
---|---|---|---|---|---|
1 | F/53 | Small intestine | EII1 | CR | 69 |
2 | M/54 | Stomach | EIV | CR | 71 |
3 | F/75 | Stomach | EIV | Lymphoma-related death | 4 |
4 | M/63 | Ileocoecal region | EIII | Lymphoma-related death | 25 |
5 | F/83 | Stomach | EIV | CR | 15 |
6 | F/89 | Small intestine | EIV | Lymphoma-related death | 0.5 |
7 | F/78 | Stomach | EII1 | Lymphoma-related death | 7 |
8 | F/62 | Stomach | EII1 | CR | 62 |
9 | F/46 | Stomach | EIV | Lymphoma-related death | 12 |
10 | M/62 | Stomach | EIV | CR | 46 |
11 | F/41 | Stomach | EI2 | CR | 1 |
12-151 | M/63 | Stomach | EII1 | Lymphoma-related death | 3 |
13-151 | M/46 | Stomach | EII1 | CR | 39 |
14-151 | M/68 | Stomach | EII1 | Lymphoma-related death | 0.5 |
15-151 | M/79 | Stomach | EII1 | Lymphoma-related death | 3 |
16-151 | M/74 | Small intestine | EIV | Lymphoma-related death | 23 |
17 | F/43 | Stomach | EI | CR | 86 |
18 | F/74 | Ileocoecal region | EII1 | Lymphoma-related death | 101 |
19 | M/63 | Stomach | EI | CR | 48 |
20 | F/80 | Stomach | EII1 | CR | 40 |
21 | F/71 | Stomach | EI2 | CR | 29 |
22 | F/74 | Ileocoecal region | EIV | Lymphoma-related death | 13 |
23 | M/80 | Stomach | Biopsy-152 | CR | 36 |
24 | F/89 | Small intestine | EI1 | CR | 91 |
25-151 | F/77 | Stomach | EII1 | Lymphoma-related death | 4 |
26-151 | F/41 | Stomach | EII1 | CR | 72 |
27 | F/77 | Stomach | EI2 | CR | 47 |
28 | M/74 | Stomach | EI2 | CR | 68 |
29 | M/81 | Stomach | EI1 | Lymphoma-related death | 3 |
30 | M/74 | Stomach | EI1 | CR | 72 |
31 | M/23 | Stomach | EI2 | Lost during follow-up | — |
Case . | Sex/Age . | Organ . | Initial Stage-150 . | Current Status . | Survival in mo . |
---|---|---|---|---|---|
1 | F/53 | Small intestine | EII1 | CR | 69 |
2 | M/54 | Stomach | EIV | CR | 71 |
3 | F/75 | Stomach | EIV | Lymphoma-related death | 4 |
4 | M/63 | Ileocoecal region | EIII | Lymphoma-related death | 25 |
5 | F/83 | Stomach | EIV | CR | 15 |
6 | F/89 | Small intestine | EIV | Lymphoma-related death | 0.5 |
7 | F/78 | Stomach | EII1 | Lymphoma-related death | 7 |
8 | F/62 | Stomach | EII1 | CR | 62 |
9 | F/46 | Stomach | EIV | Lymphoma-related death | 12 |
10 | M/62 | Stomach | EIV | CR | 46 |
11 | F/41 | Stomach | EI2 | CR | 1 |
12-151 | M/63 | Stomach | EII1 | Lymphoma-related death | 3 |
13-151 | M/46 | Stomach | EII1 | CR | 39 |
14-151 | M/68 | Stomach | EII1 | Lymphoma-related death | 0.5 |
15-151 | M/79 | Stomach | EII1 | Lymphoma-related death | 3 |
16-151 | M/74 | Small intestine | EIV | Lymphoma-related death | 23 |
17 | F/43 | Stomach | EI | CR | 86 |
18 | F/74 | Ileocoecal region | EII1 | Lymphoma-related death | 101 |
19 | M/63 | Stomach | EI | CR | 48 |
20 | F/80 | Stomach | EII1 | CR | 40 |
21 | F/71 | Stomach | EI2 | CR | 29 |
22 | F/74 | Ileocoecal region | EIV | Lymphoma-related death | 13 |
23 | M/80 | Stomach | Biopsy-152 | CR | 36 |
24 | F/89 | Small intestine | EI1 | CR | 91 |
25-151 | F/77 | Stomach | EII1 | Lymphoma-related death | 4 |
26-151 | F/41 | Stomach | EII1 | CR | 72 |
27 | F/77 | Stomach | EI2 | CR | 47 |
28 | M/74 | Stomach | EI2 | CR | 68 |
29 | M/81 | Stomach | EI1 | Lymphoma-related death | 3 |
30 | M/74 | Stomach | EI1 | CR | 72 |
31 | M/23 | Stomach | EI2 | Lost during follow-up | — |